Thursday, October 9, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

JMP Securities Analyst Initiates Coverage on Acrivon Therapeutics with Market Outperform Rating and 14 Target Price

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, Silvan Tuerkcan, an analyst at JMP Securities, began covering Acrivon Therapeutics (NASDAQ: ACRV) with an optimistic Market Outperform rating and a target price of $14. Tuerkcan’s analysis indicates a promising future for Acrivon Therapeutics, forecasting a substantial rise in stock value backed by favorable analyst assessments and institutional support.

ACRV Stock Price Soars 17.28% on March 2, 2024: Potential for Further Growth Ahead

On March 2, 2024, ACRV stock experienced a significant increase in price momentum. The stock closed at $5.70, which was a $0.84 increase from the previous market close, representing a substantial 17.28% rise in the stock price for the day.

Despite this impressive price increase, ACRV is still trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may have room to grow further, as it is currently undervalued compared to its historical performance.

Overall, the strong performance of ACRV on March 2, 2024, demonstrates the potential for growth in the stock. Investors should keep an eye on future developments and market trends to capitalize on any further opportunities for profit.

ACRV Stock Reports Decline in Net Income and EPS on March 2, 2024

On March 2, 2024, ACRV stock experienced a decline in its net income compared to the previous year and quarter. The company reported a net income of -$31.17 million over the past year, which represents a significant decrease of 91.88% from the previous year. In the third quarter, ACRV reported a net income of -$14.47 million, reflecting a decrease of 3.97% from the previous quarter.

Similarly, the earnings per share (EPS) for ACRV also saw a decline in performance. The EPS was reported at -$1.42 over the past year, marking a decrease of 82.59% from the previous year. In the third quarter, the EPS was reported at -$0.66, showing a decrease of 3.44% from the previous quarter.

Unfortunately, the total revenue for ACRV is currently unavailable, so it is difficult to assess the overall financial performance of the company on March 2, 2024. However, based on the information provided, it is evident that ACRV has experienced a decline in both net income and EPS, indicating potential challenges in the company’s financial performance.

Investors and analysts will likely closely monitor ACRV’s future financial reports to assess whether the company can improve its financial performance and reverse the negative trends seen in the past year and quarter. It will be important for ACRV to address any underlying issues affecting its profitability and work towards achieving sustainable growth in the future.

Tags: ACRV
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Data analytics stock Trading

Title Bearish Sentiment Grows for Arista Networks NYSEANET as Unusual Options Activity Surges

Retail Market Capitalization

UBS Analyst Maintains Neutral Rating on Best Buy Co with Increased Price Target

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Mixed Analyst Opinions on Bruker NASDAQ BRKR

Recommended

Finance_ Chart Down

Intuits Dividend Payout and Commitment to Shareholders

2 years ago
Freeport-McMoRan Stock

Freeport-McMoRan Faces Prolonged Crisis Following Mine Catastrophe

1 week ago
Thermo Fisher Stock

Thermo Fisher Secures $2.5 Billion in Debt Offering to Fuel Growth Ambitions

1 week ago
Micron Stock

Micron’s AI-Driven Surge Powers Record Financial Performance

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Security Concerns Rattle Palantir Investors Following Military Report

Apple Leadership Transition Gains Momentum as Successor Emerges

Alphabet’s AI Ambitions Face Critical Earnings Test

QuantumScape Shares Surge Amid Strategic Expansion and Upcoming Financial Report

NuScale Power Shares Slide Ahead of Earnings Release

Defense Giant Lockheed Martin Ramps Up Production Amid Global Tensions

Trending

3M Stock
Analysis

3M Considers Major Business Unit Divestment in Strategic Overhaul

by Andreas Sommer
October 9, 2025
0

Industrial conglomerate 3M is reportedly evaluating one of the most significant portfolio restructuring moves in its recent...

Bristol-Myers Squibb Stock

Bristol-Myers Squibb’s Alzheimer’s Therapy Gains Momentum as Investors Weigh Pipeline Against Patent Cliff

October 9, 2025
Applied Materials Stock

Semiconductor Giant Navigates Geopolitical Crosscurrents

October 9, 2025
Palantir Stock

Security Concerns Rattle Palantir Investors Following Military Report

October 9, 2025
Apple Stock

Apple Leadership Transition Gains Momentum as Successor Emerges

October 9, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • 3M Considers Major Business Unit Divestment in Strategic Overhaul
  • Bristol-Myers Squibb’s Alzheimer’s Therapy Gains Momentum as Investors Weigh Pipeline Against Patent Cliff
  • Semiconductor Giant Navigates Geopolitical Crosscurrents

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com